Same-visit endoscopic ultrasound plus ERCP for pancreaticobiliary conditions
Official title: Effect of Same-session Endoscopic Ultrasonography on Endoscopic Retrograde Cholangiopancreatography in Pancreaticobiliary Diseases: A Randomized Controlled Trial
Run by Qilu Hospital of Shandong University · NCT06978231 · Data updated 2026-11-12
We will test whether doing endoscopic ultrasound (EUS) during the same visit as ERCP changes the procedure plan and improves outcomes for adults with pancreaticobiliary diseases.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 214 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Jinan, Shandong) |
| Status | Recruiting |
| Started | June 10, 2025 |
| Main results expected | December 2026 |
| Study ends | April 2027 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT06978231 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are newly indicated for ERCP, have not had prior ERCP, and have not had pancreaticobiliary EUS within the past three months are ideal candidates.
✕Probably not a fit
Patients with unresectable malignancies needing only pathological confirmation, those requiring only palliative stenting, people with anatomy that prevents EUS, severe comorbid conditions, contrast allergy, or pregnancy are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center randomized controlled trial will enroll adults indicated for ERCP and randomize them 1:1 to same-session EUS plus ERCP versus ERCP alone. Clinical data and patient-reported outcomes are collected at baseline and during follow-up, and a structured questionnaire will record whether EUS changed the planned ERCP strategy. Secondary comparisons include complication rates, technical success, hospitalization costs, length of stay, and radiation exposure. Outcomes will be compared between groups to determine the safety and practical impact of adding same-session EUS.
Why it matters
Potential benefit: If successful, adding same-session EUS could help doctors choose better ERCP approaches during a single visit, potentially reducing complications, shortening hospital stays, and lowering radiation exposure and costs.
How similar studies have gone: Observational studies and small prospective reports indicate same-session EUS can alter management and appear safe, but randomized controlled data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients aged ≥18 years; 2. Patients with pancreaticobiliary diseases definitively indicated for ERCP (as confirmed by HBP Specialists ); 3. No prior history of ERCP; 4. No pancreaticobiliary EUS examinations within the preceding 3 months. Exclusion Criteria: 1. Patients with clinically confirmed malignant lesions deemed surgically unresectable by multidisciplinary evaluation and requiring pathological diagnosis exclusively for chemotherapy/radiotherapy guidance; 2. Patients with confirmed diagnosis requiring only palliative biliary/pancreatic stent placement for obstructive jaundice ; 3. Patients with anatomical alterations or surgical history affecting EUS feasibility; 4. Severe systemic illness including severe hepatic, renal, cardiopulmonary and cerebrovascular diseases with high risk for endoscopic procedures; 5. Contraindication to iodinated contrast media (allergy or renal impairment preventing ERCP); 6. Pregnancy or lactation; 7. Patients with severe coagulopathy; 8. Declined informed consent; 9. Severe psychiatric disorder/non-cooperation precluding safe procedure.
Where it's running
-
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Study coordinator: Zhen Li, MD,PhD
- Email: qilulizhen@sdu.edu.cn
- Phone: +86 18560086106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peripheral nerve decompression plus nerve stimulation for painful diabetic neuropathy
This study looks at whether combining nerve decompression with nerve stimulation can help reduce pain in people with painful diabetic neuropathy.
-
Compare 10 Hz rTMS vs. iTBS for teens with major depressive disorder
This study tests whether two brain-stimulation approaches work for teens ages 11–19 who have major depressive disorder, by randomly assigning them to receive either 10 Hz rTMS or iTBS over two weeks.
-
Dual-Carrier-Frequency Brain Stimulation for Chronic Low Back Pain
Researchers test a brain-stimulation method to see if it can ease chronic non-specific low back pain in adults by targeting the hippocampus, alongside standard rehab.
-
Brain network patterns in muscle pain patients measured by MEG
This study tests whether MEG brain activity and connectivity patterns differ in people with muscle pain compared to healthy controls.
-
Iris Blood Flow Measured by OCTA in Diabetic Eye Disease
This study uses a non-invasive eye scan to see if iris blood flow differs across people with Type 2 diabetes and varying eye complications, including those without eye disease and those with neovascular glaucoma.
-
Intraoperative 3D Longitude-Latitude-Depth Localization vs CT-Guided Lung Localization for Small Peripheral Nodules
This study tests whether intraoperative 3D longitude–latitude–depth localization can identify 0.8–2 cm peripheral lung nodules as reliably as the standard preoperative CT-guided localization in adults undergoing VATS surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.